Appetite Hormones in Binge Eating Disorder

NCT ID: NCT01552759

Last Updated: 2013-03-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

96 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-05-31

Study Completion Date

2012-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study investigates the hormones that the body produces in response to food intake and in response to stress, and the way that stress influences food intake. In particular, it compares the hormone levels and food intake of people with and without binge eating disorder. In order to find out how these appetite- and stress-related hormones are linked to brain activity, the study also includes an fMRI scan, a non-invasive procedure that looks at which regions of the brain are most active during a food-related scenario.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objectives are to study appetite-related hormones regulating food intake under normal conditions and following a stressor in the morning and evening (when most binge episodes occur), to help reveal biological mechanisms in BED. We plan to enroll: 32 obese Ss with BED (16m, 16f), 32 obese Ss without BED (16m, 16f) and 32 normal-weight Ss without BED (16m, 16f). Height, weight, waist circumference, and body fat will be assessed during a first appointment. On two different days separated by at least a week, Ss will ingest a fixed liquid meal once in the morning and once in the evening. Appetite ratings and collections of blood and saliva to measure hormones will continue for 2 hours after the fixed meal. This will be followed on each day by a laboratory stress protocol (Socially Evaluated Cold Pressor Test; SECPT), and then consumption of an ad libitum meal 30 minutes later. On one day during the protocol, the participant will collect saliva using a swab immediately after waking and again at 08.00. In order to capture more naturalistic eating episodes, all Ss will additionally record food intake, rate appetite, and measure salivary cortisol before and after one evening meal, and one after-dinner snack (or after-dinner binge for BED Ss). On two additional days, we will use fMRI to assess brain activation in response to high-palatability food (HPF) relative to low-palatability food (LPF) or non-food (NF) visual cues following the SECPT and a control condition using warm water. On each day, following the fMRI scan, an ad libitum meal will be consumed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Binge Eating Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Obese subjects with BED

Subjects who meet the BMI requirement for obesity (\>30 kg/m\^2) and the DSM requirements for binge eating disorder based on responses to validated questionnaires.

Subjects will undergo the postprandial responses, cold pressor test and ad libitum test meal.

Group Type EXPERIMENTAL

Postprandial responses

Intervention Type PROCEDURE

Subjects ingest a fixed meal, with blood draws to measure appetite hormone levels taken before and after the meal.

Cold pressor test

Intervention Type BEHAVIORAL

Subjects then undergo the Socially-Evaluated Cold Pressor Test, with blood draws to measure appetite hormone levels taken before and after the test.

Test meal

Intervention Type BEHAVIORAL

Subjects are presented with an ad libitum buffet meal.

Obese without BED

Subjects who meet the BMI requirement for obesity (\>30 kg/m\^2) but who do not meet the DSM requirements for binge eating disorder based on responses to validated questionnaires.

Subjects will undergo the postprandial responses, cold pressor test and ad libitum test meal.

Group Type EXPERIMENTAL

Postprandial responses

Intervention Type PROCEDURE

Subjects ingest a fixed meal, with blood draws to measure appetite hormone levels taken before and after the meal.

Cold pressor test

Intervention Type BEHAVIORAL

Subjects then undergo the Socially-Evaluated Cold Pressor Test, with blood draws to measure appetite hormone levels taken before and after the test.

Test meal

Intervention Type BEHAVIORAL

Subjects are presented with an ad libitum buffet meal.

Normal-weight without BED

Subjects with BMI 20-25 kg/m\^2 who do not meet the DSM requirements for binge eating disorder based on responses to validated questionnaires.

Subjects will undergo the postprandial responses, cold pressor test and ad libitum test meal.

Group Type EXPERIMENTAL

Postprandial responses

Intervention Type PROCEDURE

Subjects ingest a fixed meal, with blood draws to measure appetite hormone levels taken before and after the meal.

Cold pressor test

Intervention Type BEHAVIORAL

Subjects then undergo the Socially-Evaluated Cold Pressor Test, with blood draws to measure appetite hormone levels taken before and after the test.

Test meal

Intervention Type BEHAVIORAL

Subjects are presented with an ad libitum buffet meal.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Postprandial responses

Subjects ingest a fixed meal, with blood draws to measure appetite hormone levels taken before and after the meal.

Intervention Type PROCEDURE

Cold pressor test

Subjects then undergo the Socially-Evaluated Cold Pressor Test, with blood draws to measure appetite hormone levels taken before and after the test.

Intervention Type BEHAVIORAL

Test meal

Subjects are presented with an ad libitum buffet meal.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Liquid meal replacement is Boost (Nestle Nutrition).

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BMI of 20-25 or 30-50
* stable weight(± 4%) for at least 3 mo
* premenopausal and have regular menstrual cycles (28 d ± 5), not be pregnant or lactating, and not be within 1 y of childbirth
* must like pizza and be willing to consume it during the ad libitum meal

Exclusion Criteria

* significant medical or psychiatric conditions
* current and past 3-mo use of certain prescribed medications, especially those that could affect body weight, such as antidepressants and stimulants as well as smoking, or excess alcohol (\> 3 drinks/d)
* vigorously exercise for more than 6 h/wk
* left-handed, with known claustrophobia for a scanner enclosure, or have metal implants, non-removable metallic dental retainers, pacemakers, or permanent eyeliner or large tattoos that contain metallic pigment
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

St. Luke's-Roosevelt Hospital Center

OTHER

Sponsor Role collaborator

Columbia University

OTHER

Sponsor Role collaborator

New York Obesity and Nutrition Research Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Allan Geliebter

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Allan Geliebter, PhD

Role: PRINCIPAL_INVESTIGATOR

New York Obesity and Nutrition Research Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

St. Luke's Hospital

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

de Zwaan M, Mitchell JE, Raymond NC, Spitzer RL. Binge eating disorder: clinical features and treatment of a new diagnosis. Harv Rev Psychiatry. 1994 Mar-Apr;1(6):310-25. doi: 10.3109/10673229409017098.

Reference Type BACKGROUND
PMID: 9384866 (View on PubMed)

Hellstrom PM, Geliebter A, Naslund E, Schmidt PT, Yahav EK, Hashim SA, Yeomans MR. Peripheral and central signals in the control of eating in normal, obese and binge-eating human subjects. Br J Nutr. 2004 Aug;92 Suppl 1:S47-57. doi: 10.1079/bjn20041142.

Reference Type BACKGROUND
PMID: 15384323 (View on PubMed)

Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu H, Pinto S, Colmers WF, Cone RD, Horvath TL. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron. 2003 Feb 20;37(4):649-61. doi: 10.1016/s0896-6273(03)00063-1.

Reference Type BACKGROUND
PMID: 12597862 (View on PubMed)

Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, Bloom SR. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med. 2003 Sep 4;349(10):941-8. doi: 10.1056/NEJMoa030204.

Reference Type BACKGROUND
PMID: 12954742 (View on PubMed)

English PJ, Ghatei MA, Malik IA, Bloom SR, Wilding JP. Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab. 2002 Jun;87(6):2984. doi: 10.1210/jcem.87.6.8738.

Reference Type BACKGROUND
PMID: 12050284 (View on PubMed)

Monteleone P, Martiadis V, Rigamonti AE, Fabrazzo M, Giordani C, Muller EE, Maj M. Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa. Biol Psychiatry. 2005 Apr 15;57(8):926-31. doi: 10.1016/j.biopsych.2005.01.004.

Reference Type BACKGROUND
PMID: 15820714 (View on PubMed)

Monteleone P, Martiadis V, Fabrazzo M, Serritella C, Maj M. Ghrelin and leptin responses to food ingestion in bulimia nervosa: implications for binge-eating and compensatory behaviours. Psychol Med. 2003 Nov;33(8):1387-94. doi: 10.1017/s0033291703008316.

Reference Type BACKGROUND
PMID: 14672247 (View on PubMed)

Geliebter A, Yahav EK, Gluck ME, Hashim SA. Gastric capacity, test meal intake, and appetitive hormones in binge eating disorder. Physiol Behav. 2004 Jul;81(5):735-40. doi: 10.1016/j.physbeh.2004.04.014.

Reference Type BACKGROUND
PMID: 15234178 (View on PubMed)

Geliebter A, Gluck ME, Hashim SA. Plasma ghrelin concentrations are lower in binge-eating disorder. J Nutr. 2005 May;135(5):1326-30. doi: 10.1093/jn/135.5.1326.

Reference Type BACKGROUND
PMID: 15867334 (View on PubMed)

Raymond NC, Neumeyer B, Warren CS, Lee SS, Peterson CB. Energy intake patterns in obese women with binge eating disorder. Obes Res. 2003 Jul;11(7):869-79. doi: 10.1038/oby.2003.120.

Reference Type BACKGROUND
PMID: 12855757 (View on PubMed)

Walsh BT, Boudreau G. Laboratory studies of binge eating disorder. Int J Eat Disord. 2003;34 Suppl:S30-8. doi: 10.1002/eat.10203.

Reference Type BACKGROUND
PMID: 12900984 (View on PubMed)

Anderson DA, Williamson DA, Johnson WG, Grieve CO. Validity of test meals for determining binge eating. Eat Behav. 2001 Summer;2(2):105-12. doi: 10.1016/s1471-0153(01)00022-8.

Reference Type BACKGROUND
PMID: 15001040 (View on PubMed)

Geliebter A, Melton PM, McCray RS, Gallagher DR, Gage D, Hashim SA. Gastric capacity, gastric emptying, and test-meal intake in normal and bulimic women. Am J Clin Nutr. 1992 Oct;56(4):656-61. doi: 10.1093/ajcn/56.4.656.

Reference Type BACKGROUND
PMID: 1414964 (View on PubMed)

Geliebter A, Hassid G, Hashim SA. Test meal intake in obese binge eaters in relation to mood and gender. Int J Eat Disord. 2001 May;29(4):488-94. doi: 10.1002/eat.1047.

Reference Type BACKGROUND
PMID: 11285588 (View on PubMed)

Tataranni PA, Larson DE, Snitker S, Young JB, Flatt JP, Ravussin E. Effects of glucocorticoids on energy metabolism and food intake in humans. Am J Physiol. 1996 Aug;271(2 Pt 1):E317-25. doi: 10.1152/ajpendo.1996.271.2.E317.

Reference Type BACKGROUND
PMID: 8770026 (View on PubMed)

Castonguay TW. Glucocorticoids as modulators in the control of feeding. Brain Res Bull. 1991 Sep-Oct;27(3-4):423-8. doi: 10.1016/0361-9230(91)90136-8.

Reference Type BACKGROUND
PMID: 1959040 (View on PubMed)

Epel E, Lapidus R, McEwen B, Brownell K. Stress may add bite to appetite in women: a laboratory study of stress-induced cortisol and eating behavior. Psychoneuroendocrinology. 2001 Jan;26(1):37-49. doi: 10.1016/s0306-4530(00)00035-4.

Reference Type BACKGROUND
PMID: 11070333 (View on PubMed)

Koo-Loeb JH, Costello N, Light KC, Girdler SS. Women with eating disorder tendencies display altered cardiovascular, neuroendocrine, and psychosocial profiles. Psychosom Med. 2000 Jul-Aug;62(4):539-48. doi: 10.1097/00006842-200007000-00013.

Reference Type BACKGROUND
PMID: 10949100 (View on PubMed)

Kelly CB, Cooper SJ. Plasma norepinephrine response to a cold pressor test in subtypes of depressive illness. Psychiatry Res. 1998 Oct 19;81(1):39-50. doi: 10.1016/s0165-1781(98)00086-9.

Reference Type BACKGROUND
PMID: 9829649 (View on PubMed)

Gluck ME, Geliebter A, Hung J, Yahav E. Cortisol, hunger, and desire to binge eat following a cold stress test in obese women with binge eating disorder. Psychosom Med. 2004 Nov-Dec;66(6):876-81. doi: 10.1097/01.psy.0000143637.63508.47.

Reference Type BACKGROUND
PMID: 15564352 (View on PubMed)

Yanovski SZ. Binge eating disorder: current knowledge and future directions. Obes Res. 1993 Jul;1(4):306-24. doi: 10.1002/j.1550-8528.1993.tb00626.x.

Reference Type BACKGROUND
PMID: 16350580 (View on PubMed)

Geliebter A, Ladell T, Logan M, Schneider T, Sharafi M, Hirsch J. Responsivity to food stimuli in obese and lean binge eaters using functional MRI. Appetite. 2006 Jan;46(1):31-5. doi: 10.1016/j.appet.2005.09.002. Epub 2005 Dec 20.

Reference Type BACKGROUND
PMID: 16364498 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.nyorc.org/

New York Obesity and Nutrition Research Center

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

06-163

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Treatment of Binge Eating Disorder
NCT00039936 COMPLETED NA
Food and the Brain
NCT02743000 COMPLETED
Treatment of Binge Eating Disorder
NCT00041743 COMPLETED NA
Binges and Neural Variability
NCT04184856 COMPLETED
Binge Eating & Birth Control
NCT04278755 TERMINATED PHASE2